In an exclusive interview, Sally Susman, a pioneer in corporate comms, recounts finding out that Pfizer's COVID-19 vaccine ...

Last month, the World Health Organization (WHO) estimated it would take 18 months to develop a vaccine for the novel coronavirus (COVID-19). Here is an update on the progress of several major ...

A promising new COVID-19 vaccine candidate developed by researchers at the Centenary Institute and the University of Sydney ...

Pfizer received FDA approval to enroll adolescents in its COVID-19 vaccine trial. Experts say it's an important step aimed at determining whether a vaccine could be safe and effective in children.

COVID-19 brought unprecedented public attention to the development, regulation, and timeline for products that prevent deadly infections, potentially heralding an era of vaccine innovation marked ...

Development of new coronavirus vaccines may be hitting critical mass. Here’s how they work By Maggie Fox, CNN 8 minute read ...

Many of the vaccines that are in development for COVID-19 were made possible because researchers had seed funding for technologies that make rapid vaccine development possible. That funding came from ...

Covid-19 vaccine stocks are back in focus, as cases in the U.S. surge with the spread of the highly infectious Delta variant of the virus. The seven-day average for Covid-19 cases stood at around ...

As COVID-19 continues to spread across the U.S., impacting our daily lives and creating an uncertain future, the world eagerly awaits a vaccine – something that is likely 12 to 18 months away.

Some of the federal government’s top health officials are suggesting a vaccine for COVID-19 could be released in less than two months. The move would be made through a special emergency ...

Covid-19 vaccine stocks are back in focus, as cases in the U.S. surge with the spread of the highly infectious Delta variant of the virus. The seven-day average for Covid-19 cases stood at around ...